Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Method Comparison Study of the Spartan FRX CYP2C19 *2, *3, and *17 Genotyping System

NCT01718535 is registered in ClinicalTrials.gov with Spartan Bioscience Inc. as lead sponsor.

NCT NCT01718535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01718535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Method Comparison Study of the Spartan FRX CYP2C19 *2, *3, and *17 Genotyping System
Lead sponsor
Spartan Bioscience Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2012
Enrollment
327 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genotyping techniques